Patents by Inventor Johann MOLS

Johann MOLS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic Viral Vaccine
    Publication number: 20240091345
    Abstract: The present invention relates to a nucleic acid encoding a HSV2 Fc receptor or immunogenic fragment or variant thereof for use in generating a cross reactive immune response against HSV1 in a subject. Also provided is a nucleic acid encoding a HSV1 Fc receptor or immunogenic fragment or variant thereof for use in generating a cross reactive immune response against HSV2 when administered to a subject.
    Type: Application
    Filed: January 18, 2022
    Publication date: March 21, 2024
    Applicant: GlaxoSmithKline Biologicals SA
    Inventors: Johann MOLS, Marie TOUSSAINT
  • THERAPEUTIC VIRAL VACCINE
    Publication number: 20220273789
    Abstract: The present invention relates to viral Fc receptor or immunogenic fragments thereof for treating a viral infection in a subject and, in particular, a herpes vims infection. The present invention also relates to a heterodimer comprising or consisting of an Fc receptor from a HSV vims or an immunogenic fragment thereof and a binding partner from said HSV vims or a fragment thereof, for use in therapy.
    Type: Application
    Filed: July 20, 2020
    Publication date: September 1, 2022
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Normand BLAIS, Cindy CASTADO, Johann MOLS, Lionel SACCONNAY, Marie TOUSSAINT, Newton Muchugu WAHOME, Giulietta MARUGGI